Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 13, 389 (2007)
Published online: 28 March 2007 | doi:10.1038/nm0407-389
Changes to US drug safety laws take center stage
Meredith Wadman1
- Washington DC
Abstract
US Congress is weighing ways to reform the Food and Drug Administration.
The US Food and Drug Administration (FDA) moved on 9 March to toughen warning labels on a widely used class of anemia drugs, preempting a meeting in May on the issue by the agency's advisers.The announcement came days before a US Senate hearing that focused on the agency's policing of marketed drugs, with critics escalating demands that the FDA be given greater legal authority to do so.
To read this story in full you will need to login or make a payment (see right).
